Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2018/08/015387
CTRI/2018/08/015387Active, not recruiting未知

Comparative evaluation of the efficacy and safety of Dexmedetomedine on patients with and without β blocker posted for Vitreo Retinal surgery under intravenous sedation and peribulbar block - .

ETHRADHAMA SUPER SPECIALITY EYE HOSPITA0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • •1. Patients aged 40 to 75 years
  • •2. ASA grade 1 to 3
  • •3. Elective procedures posted for vitreo retinal surgery

Exclusion Criteria

  • •1. Age > 70 years
  • •2. Severe left ventricular dysfunction (Ejection fraction < 35 %)
  • •3. Baseline heart rate < 40 bpm
  • •4. Hypovolemia with systolic blood pressure < 90 mmHg
  • •5. Second and third degree heart block
  • •6. Chronic renal failure and hepatic impairment
  • •7. Bleeding or coagulation abnormalities
  • •8. Psychiatric diseases
  • •9. H/o allergy to the drug

Investigators

Sponsor
ETHRADHAMA SUPER SPECIALITY EYE HOSPITA

Similar Trials

Recruiting
Phase 3
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1
IRCT20130812014333N145Kermanshah University of Medical Sciences80
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19
IRCT20130812014333N147Kermanshah University of Medical Sciences80
Recruiting
Phase 2
evaluation the effect of botulinum toxin type A for treating frown linesskin rejuvenation.
IRCT20150101020514N8Imen vaccine alborz Company140
Completed
Not Applicable
Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.overactive bladder
JPRN-UMIN000004354Department of Urology, Kanto Rosai Hospital60
Recruiting
Phase 4
Study to compare which iron preparations is better for treatment of anaemic in patients of chronic kidney disease.
CTRI/2017/08/009343Jawaharlal Nehru Medical College Hospital